Literature DB >> 1698472

Rat cerebral cortical synaptoneurosomal membranes. Structure and interactions with imidazobenzodiazepine and 1,4-dihydropyridine calcium channel drugs.

J Moring1, W J Shoemaker, V Skita, R P Mason, H C Hayden, R M Salomon, L G Herbette.   

Abstract

Small angle x-ray scattering has been used to investigate the structure of synaptoneurosomal (SNM) membranes from rat cerebral cortex. Electron micrographs of the preparation showed SNM with classical synaptic appositions intact, other vesicles, occasional mitochondria, and some myelin. An immunoassay for myelin basic protein placed the myelin content of normal rat SNM at less than 2% by weight of the total membrane present. X-Ray diffraction patterns showed five diffraction orders with a unit cell repeat for the membrane of 71 to 78 A at higher hydration states. At lower hydration, 11 orders appeared; the unit cell repeat was 130 A, indicating that the unit cell contained two membranes. Electron density profiles for the 130-A unit cell were determined; they clearly showed the two opposed asymmetrical membranes of the SNM vesicles. SNM membrane/buffer partition coefficients (Kp) of imidazobenzodiazepine and 1,4-dihydropyridine (DHP) calcium channel drugs were measured; Kp's for DHP drugs were approximately five times higher in rabbit light sarcoplasmic reticulum than in SNM. Ro 15-1788 and the DHP BAY K 8644 bind primarily to the outer monolayer of vesicles of intact SNM membranes. Nonspecific equilibrium binding of Ro 15-1788 occurs mainly in the upper acyl chain of the bilayer in lipid extracts of SNM membrane.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1698472      PMCID: PMC1280991          DOI: 10.1016/S0006-3495(90)82396-1

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  35 in total

1.  Asymmetric structure of the purple membrane.

Authors:  A E Blaurock; G I King
Journal:  Science       Date:  1977-06-03       Impact factor: 47.728

2.  The picomole determination of free and total cholesterol in cells in culture.

Authors:  J G Heider; R L Boyett
Journal:  J Lipid Res       Date:  1978-05       Impact factor: 5.922

3.  Interaction of 1,4 dihydropyridine calcium channel antagonists with biological membranes: lipid bilayer partitioning could occur before drug binding to receptors.

Authors:  L G Herbette; Y M Vant Erve; D G Rhodes
Journal:  J Mol Cell Cardiol       Date:  1989-02       Impact factor: 5.000

4.  Ethanol stimulates gamma-aminobutyric acid receptor-mediated chloride transport in rat brain synaptoneurosomes.

Authors:  P D Suzdak; R D Schwartz; P Skolnick; S M Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

5.  Structural studies of a membrane-bound acetylcholine receptor from Torpedo californica.

Authors:  M J Ross; M W Klymkowsky; D A Agard; R M Stroud
Journal:  J Mol Biol       Date:  1977-11       Impact factor: 5.469

6.  Structure determination of asymmetric membrane profiles using an iterative Fourier method.

Authors:  R M Stroud; D A Agard
Journal:  Biophys J       Date:  1979-03       Impact factor: 4.033

7.  Partitioning and location of Bay K 8644, 1,4-dihydropyridine calcium channel agonist, in model and biological membranes.

Authors:  R P Mason; G E Gonye; D W Chester; L G Herbette
Journal:  Biophys J       Date:  1989-04       Impact factor: 4.033

8.  An analysis of lamellar x-ray diffraction from disordered membrane multilayers with application to data from retinal rod outer segments.

Authors:  S Schwartz; J E Cain; E A Dratz; J K Blasie
Journal:  Biophys J       Date:  1975-12       Impact factor: 4.033

9.  X-ray diffraction study of myelin structure in immature and mutant mice.

Authors:  D A Kirschner; R L Sidman
Journal:  Biochim Biophys Acta       Date:  1976-09-21

10.  Increased dihydropyridine-sensitive calcium channels in rat brain may underlie ethanol physical dependence.

Authors:  S Dolin; H Little; M Hudspith; C Pagonis; J Littleton
Journal:  Neuropharmacology       Date:  1987 Feb-Mar       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.